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Abstract
Background: Trachoma, caused by ocular infection with Chlamydia trachomatis, is the leading infectious cause of
blindness worldwide. We conducted the first population-based trachoma prevalence survey in the Casamance region
of Senegal to enable the Senegalese National Eye Care Programme (NECP) to plan its trachoma control activities. The
World Health Organization (WHO) guidelines state that any individual with trachomatous trichiasis (TT) should be
offered surgery, but that surgery should be prioritised where the prevalence is >0.1%, and that districts and communities
with a trachomatous inflammation, follicular (TF) prevalence of ≥10% in 1–9 year-olds should receive mass antibiotic
treatment annually for a minimum of three years, along with hygiene promotion and environmental improvement,
before re-assessing the prevalence to determine whether treatment can be discontinued (when TF prevalence in
1–9 year-olds falls <5%).
Methods: Local healthcare workers conducted a population-based household survey in four districts of the Bignona
Department of Casamance region to estimate the prevalence of TF in 1–9 year-olds, and TT in ≥15 year-olds. Children’s
facial cleanliness (ocular and/or nasal discharge, dirt on the face, flies on the face) was measured at time of examination.
Risk factor questionnaires were completed at the household level.
Results: Sixty communities participated with a total censused population of 5580 individuals. The cluster-, age- and sex-
adjusted estimated prevalence of TF in 1–9 year-olds was 2.5% (95% Confidence Interval (CI) 1.8–3.6) (38/1425) at the
regional level and <5% in all districts, although the upper 95%CI exceeded 5% in all but one district. The prevalence of TT
in those aged ≥15 years was estimated to be 1.4% (95%CI 1.0–1.9) (40/2744) at the regional level and >1% in all districts.
Conclusion: With a prevalence <5%, TF does not appear to be a significant public health problem in this region.
However, TF monitoring and surveillance at sub-district level will be required to ensure that elimination targets
are sustained and that TF does not re-emerge as a public health problem. TT surgery remains the priority for
trachoma elimination efforts in the region, with an estimated 1819 TT surgeries to conduct.
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Background
Trachoma is the leading infectious cause of blindness
worldwide [1]. Repeated ocular infections with the bac-
terium Chlamydia trachomatis can lead to subepithelial
follicles (trachomatous inflammation, follicular (TF))
and/or inflammation (trachomatous inflammation, in-
tense (TI)). TF and TI are referred to as active trachoma,
which is usually found in children. After years of infec-
tion, trachomatous scarring (TS) can occur, resulting in
the eyelid contracting and causing the eyelashes to turn
inwards and scratch the cornea (trachomatous trichiasis,
TT), leading to corneal opacity and blindness [2].
The World Health Assembly has set a target for the
Global Elimination of Blinding Trachoma by the year
2020 (GET 2020) [3], to be achieved through implementa-
tion of the SAFE strategy for trachoma control: Surgery
for TT, Antibiotics to treat active disease, Face washing
and Environmental improvement. The latest World
Health Organization (WHO) guidelines are that any indi-
vidual with TT should be offered surgery, but that surgery
should be prioritised where the prevalence is >0.1%. Elim-
ination of TT as a public health problem is achieved when
there are fewer than 2 cases of TT unknown to the health
system per 1000 adults aged 15 years or above at the dis-
trict level (or <1 case per 1000 total population) [4, 5].
Districts and communities with a TF prevalence of ≥10%
in 1–9 year-olds should receive mass antibiotic treatment
annually for a minimum of three years, before re-assessing
the prevalence to determine whether treatment can be
discontinued (when TF prevalence in 1–9 year-olds falls
<5%) [4]. There are no recommendations for the use of
facial cleanliness and environmental improvement indica-
tors for the assessment of trachoma elimination, but these
SAFE strategy components should be implemented at any
TF prevalence level [4–6].
The dry, arid, Sahel belt of West Africa reports some of
the highest prevalence rates for TF and TT [7]. In The
Gambia, trachoma was the second leading cause of blind-
ness in 1986 [8], but following formation of the National
Eye Health Programme (NEHP) which implemented trach-
oma control activities, the prevalence of active trachoma in
0–14 year-olds decreased from 10.4% to 4.9% (a 54% re-
duction) by 1996 [9]. In 2006, TF prevalence in 1–9 year-
olds remained ≥10% in two Gambian regions (12.3% and
10.0%) [10], and mass drug administration (MDA) with
azithromycin was initiated in 11 rural districts. In 2011, re-
sults from the Partnership for the Rapid Elimination of
Trachoma (PRET) showed that the overall TF prevalence
in four districts was 2.8% (compared to 6.5% at baseline in
2008) [11]. The Gambia’s NEHP has subsequently reported
national prevalences of TF ranging between 0.2 and 3.2%,
and TT ranging between 0 and 1.7%, suggesting that The
Gambia has reached the elimination target for TF but that
further efforts are needed to reduce the burden of TT [12].
Similarly in Mali, the National Blindness Prevention
Programme (PNLC)’s trachoma control programme
formed in 1998 has helped reduce TF prevalence from a
range of 23.1–46.7% in the 1990’s to below 10% in 84% of
districts in 2013 [13]. Approximately 27,000 more TT sur-
geries are required to meet the elimination of trachoma as
a public health problem target of fewer than two cases of
TT unknown to the health system per 1000 persons aged
≥15 years [4, 5]. Trachoma prevalence data from Guinea
Bissau are limited, but a population-based prevalence sur-
vey in the Bijagós Archipelago found 22.0% active trach-
oma in 1–9 year-olds, and prevalence of TT is reported to
be 3.5% [14].
In Senegal, whose northern regions lie to the west of
the Sahel area, the last national trachoma survey was
conducted in 2000, and showed that 10.8% of children
aged less than 10 years had active trachoma, 2.6% of
women aged over 14 years had TT, and 1.4% of women
aged more than 14 years had corneal opacity [15]. A
study conducted in 2004 in the Nioro department
(within Kaolack Region, which had a prevalence of 6.8%
in the 2000 survey), had an active trachoma prevalence
of 17.4% in children aged 2–5 years [16]. These results
demonstrate that trachoma is a public health problem in
Senegal, with heterogeneity throughout the country. The
Senegalese national programme for trachoma control
began in 2004, and mass treatment of districts com-
menced in 2005.
The Casamance region of Senegal (Fig. 1), which
underwent low-level conflict for approximately 20 years
since the 1990’s, was not included in the national
trachoma survey, and therefore the appropriate SAFE
trachoma control efforts could not be targeted or im-
plemented. A prevalence survey in the Casamance re-
gion was needed so that the Senegalese National Eye
Care Programme (NECP) could plan its trachoma con-
trol activities (number of TT operations, requirements
for mass antibiotic treatment, and whether hygiene and
sanitation interventions were needed). Furthermore,
capacity building was required in this region to enable
the NECP to conduct its own trachoma prevalence sur-
veys to assess control intervention needs and impact,
and provide data to the WHO.
The aim of the study was to conduct a population-
based TF and TT prevalence survey of the Bignona
Department of the Casamance region of Senegal. The
specific objectives were to:
1. Assess the prevalence of TF in children aged 1–9 years
at the regional, district, commune and community
levels.
2. Assess the prevalence of TT in adults aged ≥15 years
at the regional, district, commune and community
levels.
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Methods
Training
To increase trachoma assessment capacity within the re-
gion, a total of 45 individuals (community members, vil-
lage health workers and community nurses) from the
Casamance region were selected by the Bignona cataract
surgeon to be trained. Training took place between 7th–
11th December 2009 (three classroom days and two days
in the field) and encompassed trachoma grading based
on the WHO simplified grading system [17] (practised
every day using projected photographs with a focus on
the clinical signs of active trachoma), survey methods,
field practice of trachoma grading and data collection,
and data recording. On the final day, the trainees were
formally tested on their trachoma grading (grading pro-
jected photographs) and data recording skills (written
exam). 40/45 trainees achieved the required trachoma
grading agreement kappa score of ≥0.8 against the
trainer, and were certified to perform trachoma grading
for the survey. They formed four teams of ten trainees,
five of whom did trachoma grading and five of whom
filled in the forms. Fieldwork took place between January
and May 2010.
Sample size calculation
We used the WHO-recommended sample size calcula-
tion method for programme managers [6]. The WHO
recommends that trachoma prevalence estimates should
be collected at the district level, with population sizes
between 100,000 and 250,000, as this is the normal ad-
ministrative unit for SAFE implementation [4, 18]. A
census (number of inhabitants only) had been conducted
by the Casamance NECP team of all villages in the
Bignona Department of Casamance (Fig. 1), comprising
the districts of Diouloulou, Sindian, Tendouck and
Tenghori, hereafter referred to as the regional level, to-
talling a population of 232,427. Thus the sample size cal-
culation was based at the regional level, as this
population size equates to that of a standard district
according to WHO definitions.
Based on the census population size and the assump-
tion, derived from previous work in the neighbouring
country of The Gambia [19], that a third of the population
was aged 1–9 years, it was estimated that there were
77,480 children in the region. Assuming an active trach-
oma prevalence of 20% [15, 20], using a precision estimate
of ±5%, an alpha risk of 5%, and a design effect of 4, a
sample size of 2732 children aged 1–9 years was calcu-
lated [6]. We set the cluster size to 50 children, thereby re-
quiring 55 communities to be included in the survey. We
included 60 communities, to ensure the sample size re-
quirements were met. The total population size (232,427)
was divided by the desired number of communities (60) to
set the sampling interval (3874). A list of the censused
communities and their cumulative population size was
compiled. A random number between 1 and 3874 was se-
lected and the community whose cumulative population
equalled this number was the first community selected.
The sampling interval was then added and communities
selected from the cumulative population size list, until 60
communities were chosen.
Any community with a population above 1000 people
was divided into two, using a logical demarcation (e.g.
road), and one area was randomly selected for inclusion
Fig. 1 Map of Senegal. Casamance region shaded in purple. Bignona Department included in the survey highlighted in red. Source data: authors
and open source information
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in the survey. Communities in the rural communes (the
next administrative level after districts) of Sindian and
Iles Karone, where higher trachoma prevalence was ex-
pected, were over-sampled by halving the sampling
interval, to help identify trachoma hot-spots to ensure
trachoma control efforts were appropriately imple-
mented. Urban communes of Bignona, Tenghori Trans-
gambienne, and Thionck-Essyl were under-sampled by
doubling the sampling interval, based on the assumption
that they would have lower prevalence and would be
more difficult to sample and survey.
Sampling selection
We followed standard population-based prevalence survey
methodology [21]. We employed a two-stage cluster ran-
dom sampling strategy, with probability of selection pro-
portional to size. In the first stage, the 60 communities
were randomly selected, resulting in 17, 18, 5 and 20 com-
munities being selected in the districts of Diouloulou,
Tenghori, Tendouck and Sindian, respectively (Table 1).
In the second stage, we made a list of household heads
with which to make a random selection of ten households
in each selected community, with three reserve house-
holds in case any of the selected households could or
would not participate.
The survey teams then enumerated all household
members who had slept in the household the night be-
fore (the de facto population) for the randomly selected
households in the randomly selected communities. Risk
factor questionnaires, including questions on sex of the
household head, ethnic group, occupation, education
level, access to a latrine, type of water source and time
to fetch water (return journey), were completed. The
questions were based on those from questionnaires pre-
viously used in The Gambia [22]; responses were not
confirmed by observational data.
Attempts were made to examine the eyes of all house-
hold members recorded during the census for trachoma
clinical signs according to the WHO simplified grading
system [17]: trachomatous inflammation, follicular (TF),
trachomatous inflammation, intense (TI), trachomatous
scarring (TS), trachomatous trichiasis (TT) and corneal
opacity (CO). Dirt on the face, nasal and ocular dis-
charge, and flies on the face at the time of examination
(measures of facial cleanliness) were recorded. The
examination team returned to households where cen-
sused individuals were not present for the first examin-
ation visit, in order to increase screening rates.
Statistical analyses
Data were double entered by different data entry clerks
into a Microsoft Access database (v. 2007). Data cleaning
and analyses were conducted in Stata (v12, STATA
Corp., College Station, TX, USA). Discrepancies between
the databases were resolved by a third individual by re-
ferring to the paper forms.
TF and TT prevalences and their 95% Confidence Inter-
vals (CIs) were estimated for children aged 1–9 years and
for individuals aged ≥15 years, respectively, using Stata’s
“svy: proportions” commands. These estimates were
weighted to allow for under/over sampling of communes,
using a weight calculated by dividing the proportion of the
region that would be expected in the sample (if each com-
mune was sampled proportional to size) by the proportion
observed in the sample. The data were also weighted by
age and gender to allow for differences in non-response
across age groups and genders. Age was weighted using
three-year age bands for 1–9 year-olds, and five-year age
bands for ≥15 year-olds. Where prevalence was 0%, the CIs
were calculated using the Clopper-Pearson exact method.
Prevalence is reported at region and district levels for
healthcare management purposes [4], and at commune
and community levels for epidemiological interest pur-
poses. Characteristics from the risk factor questionnaire
are reported for the censused population, children (aged
1–9 years) examined, and adults (aged ≥15 years) exam-
ined, but formal risk factor analyses were not conducted
due to insufficient statistical power resulting from low
trachoma prevalence.
The spatial distribution of TF and TT prevalence is
presented using ArcMap v9.2 (Environmental Systems
Research Institute, Inc. Redlands, CA, USA). Commu-
nity GPS coordinates were collected in the field. Open
source maps (www.openstreetmap.org) were obtained
from CloudMade.org.
Results
Study participation
Of the 60 randomly selected communities, all consented
to participate. Ten randomly selected households per
community were included, except in one community
where only nine households were approached. A total of
5580 individuals were censused, of which 1554 (27.8%)
were aged 1–9 years (supporting the TF sample size calcu-
lation assumption) and 3121 (55.9%) were aged ≥15 years
(Table 2). A total of 1432 children aged 1–9 years were
examined, and 2750 adults aged ≥15 years. Individual par-
ticipation in the study was high, at 92.1% for 1–9 year-olds
and 88.1% for those aged ≥15 years (Table 2). 90.4% of
censused females were examined for TT compared to
85.4% of males (chi-squared p = 0.287) (Table 2).
Overview of study population
Children’s faces were relatively clean, with <6% recorded
as having dirt on their faces, ocular discharge or flies on
their faces at the time of examination (Table 3). How-
ever, 14.7% were reported as having nasal discharge. The
majority (82.2%) of household heads were male, with
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Table 1 Prevalence of trachomatous inflammation, follicular (TF) and trachomatous trichiasis (TT)
TF TT
Commune No.
communities
No. 1–9 year-olds
with TF results
No. with
TF (%)
Adjusted TF, %
(95%CI)a
No. ≥15 year-olds
with TT results
No. with
TT (%)
Adjusted TT, %
(95%CI)a
Region (Bignona
Department of Casamance)
60 1425 38 (2.7) 2.5 (1.8–3.6) 2744 40 (1.5) 1.4 (1.0–1.9)
Sindian District 20 461 15 (3.3) 3.0 (1.5–5.9) 938 15 (1.6) 1.5 (0.8–2.7)
Suelle 3 63 1 (1.6) 1.7 (0.2–11.5) 123 4 (3.3) 3.2 (1.2–8.4)
Djibidione 2 46 1 (2.2) 2.0 (0.3–13.6) 64 0 (0.0) 0.0 (0.0–11.5)
Sindianb 6 136 4 (2.9) 3.0 (1.1–7.7) 297 4 (1.3) 1.3 (0.5–3.5)
Oulampane 5 147 8 (5.4) 5.4 (2.7–10.6) 281 6 (2.1) 2.1 (0.9–4.6)
Mangagoulack 2 30 0 (0.0) 0.0 (0.0–11.6) 79 1 (1.3) 1.3 (0.2–9.3)
Thionck-Essylc 2 39 1 (2.6) 3.0 (0.4–19.8) 94 0 (0.0) 0.0 (0.0–13.5)
Tenghori District 18 389 6 (1.5) 1.8 (0.8–4.2) 812 10 (1.2) 1.1 (0.6–1.9)
Bignonac 5 100 2 (2.0) 2.0 (0.5–7.8) 265 2 (0.8) 0.7 (0.2–2.9)
Tenghori 3 61 1 (1.6) 1.6 (0.2–11.3) 98 2 (2.0) 1.8 (0.4–6.9)
Tenghori
Transgambiennec
2 39 2 (5.1) 4.9 (1.2–18.7) 83 0 (0.0) 0.0 (0.0–17.3)
Ouonck 3 78 0 (0.0) 0.0 (0.0–4.6) 137 3 (2.2) 2.3 (0.7–6.9)
Coubalan 3 70 0 (0.0) 0.0 (0.0–5.1) 159 2 (1.3) 1.3 (0.3–5.3)
Niamone 2 41 1 (2.4) 2.7 (0.3–18.1) 70 1 (1.4) 1.7 (0.2–11.6)
Tendouck District 5 108 2 (1.9) 2.1 (0.4–9.7) 235 6 (2.6) 2.6 (1.7–4.0)
Balinghor 1 26 1 (3.8) 4.1 (0.5–26.9) 55 1 (1.8) 1.6 (0.2–11.4)
Karthiackk 2 32 1 (3.1) 3.3 (0.4–22.1) 79 2 (2.5) 2.7 (0.6–10.7)
Diegoune 2 50 0 (0.0) 0.0 (0.0–7.1) 101 3 (3.0) 2.9 (0.9–8.9)
Diouloulou District 17 467 15 (3.2) 3.1 (1.9–5.1) 759 9 (1.2) 1.2 (0.5–3.0)
Djinaky 4 97 3 (3.1) 2.3 (0.7–7.3) 190 2 (1.1) 0.9 (0.2–3.4)
Kafountine 4 106 4 (3.8) 3.8 (1.4–9.8) 183 1 (0.5) 0.5 (0.1–3.7)
Iles Karoneb 3 47 2 (4.3) 4.6 (1.1–17.3) 80 4 (5.0) 4.9 (1.8–12.5)
Diouloulou 6 217 6 (2.8) 2.8 (1.3–6.1) 306 2 (0.7) 0.7 (0.2–2.7)
aPrevalences are adjusted for non-response by age and sex. Region and district estimates are additionally weighted by commune size. 95% Confidence Intervals
(95%CIs) are logit-transformed confidence limits. Where prevalence is zero, one-sided 97.5% Clopper-Pearson exact CIs are presented
bRural commune (communities over-sampled by halving the sampling interval)
cUrban commune (communities under-sampled by doubling the sampling interval)
Table 2 Age and sex distribution of participants censused and examined
Age
(years)
Number
censuseda
Number
(%) examined
Number (%) not examined
Absent Refused Other reason/no reason provided
Males
1–9 813 742 (91.3)b 70 (8.6) 0 (0.0) 1 (0.1)
≥15 1421 1214 (85.4) 196 (13.8) 5 (0.4) 6 (0.4)
Females
1–9 741 690 (93.1)b 47 (6.3) 4 (0.5) 0 (0.0)
≥15 1700 1536 (90.4) 161 (9.5) 3 (0.2) 0 (0.0)
Total 4675 4182 (89.5) 474 (10.1) 12 (0.3) 7 (0.1)
aAge missing for 48 individuals
bCould not evert eyelid in seven examined children aged 1–9 years (3 males, 4 females)
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Diola the dominant ethnic group (82.4%), and agriculture
was the main occupation (66.3%). Over half of adults had
attended school (54.2%), the majority to primary level only
(59.0%). Most households (88.4%) had access to a latrine,
with over half of these (52.4%) being privately owned. The
predominant water source was an uncovered well outside
of the household (51.0%), with most adults (90.4%) report-
ing it took <30 min to fetch water.
Prevalence of clinical signs
The prevalences presented for TF and TT are weighted
for the cluster size relative to the total community popu-
lation size as per the census provided by the Casamance
region NECP team, and age- and sex-adjusted against
those censused, but not examined, in our study.
TF in 1–9 year-olds
One thousand four hundred thirty-two children aged 1–
9 years were examined for clinical signs of trachoma, with
TF results available for 1425 (Table 1). At the regional
level, TF was found in 38 (2.5%, 95%CI 1.8–3.6) children
aged 1–9 years. At the district level, the prevalence of TF
was <5% in all districts, although the upper 95%CI
exceeded 5% in all but the district of Tenghori.
At the commune level, none of the 19 communes had a
prevalence ≥10%, and only one (Oulampane) had a TF
prevalence ≥5%. The rural communes of Sindian and Iles
Karone, in which communities were over-sampled due to
expected higher trachoma prevalence, had the 8th and 3rd
highest TF prevalences, at 3.0% (95%CI 1.1–7.7) and 4.6%
(95%CI 1.1–17.3), respectively. The urban communes
(Bignona, Tenghori Transgambienne and Thionck-Essyl)
in which communities were under-sampled due to ex-
pected lower trachoma prevalence and difficult survey lo-
gistics, had the 2nd, 7th and 12th highest TF prevalences.
The highest TF prevalence commune was Oulampane
(5.4%, 95%CI 2.7–10.6) in Sindian district.
At the community level, only two of the 60 communi-
ties had a TF prevalence ≥10% (Tenghory 1 zone 1 in
Table 3 Population characteristics
Characteristic No. (%)a
Total censused population 5580
Sex
Male 2726 (48.9)
Female 2854 (51.1)
Age (years)
1–9 1554 (27.8)
≥15 3121 (55.9)
Examined children (1–9 years) characteristics 1432
Dirt on the face 77 (5.4)
Ocular discharge 35 (2.4)
Nasal discharge 210 (14.7)
Flies on face at time of examination 5 (0.3)
Examined adult (≥15 years) characteristics 3121
Household head characteristics
Sex
Male 2564 (82.2)
Female 557 (17.8)
Ethnicity
Diola 2573 (82.4)
Peulh 98 (3.1)
Mandingue 164 (5.3)
Other 286 (9.2)
Occupation
Agriculture 2068 (66.3)
Trader 140 (4.5)
Teacher 109 (3.5)
No activity 123 (3.9)
Other 681 (21.8)
Whether attended formal education
Yes 1690 (54.2)
No 1429 (45.8)
Highest education level reached
Primary 997 (59.0)
Secondary 621 (36.7)
University 72 (4.3)
Household characteristics
Access to a latrine (shared or private)
Yes 2754 (88.4)
No 360 (11.6)
Latrine ownership
Shared 1312 (47.6)
Private 1442 (52.4)
Principal water source
Well inside household 925 (29.7)
Table 3 Population characteristics (Continued)
Tap inside household 444 (14.2)
Uncovered well outside household 1590 (51.0)
Outside covered well with pump 67 (2.1)
Outside tap 51 (1.6)
Other 42 (1.3)
Habitual time to fetch waterb
Less than time to cook rice 2811 (90.4)
Same as the time to cook rice 190 (6.1)
More than the time to cook rice 110 (3.5)
aWhere data were missing, percentages are based on denominators for which
data are available
bTime was contextualised as the time to cook rice (approximately 30 min)
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the commune of Tenghori Transgambienne (10.3%,
95%CI 1.5–45.8), and Silinkine in the commune of
Oulampane (15.2%, 95%CI 1.5–67.7)) (Fig. 2), and 10
had a prevalence between 5% and 10%. Thirty-four com-
munities had a prevalence of 0%.
Trachomatous trichiasis (TT) in ≥15 year-olds
Two thousand seven hundred fifty adults aged ≥15 years
were examined, with TT results available for 2744 (Table
1). At the regional level, a total of 40 TT cases was found
(1.4%, 95% CI 1.0–1.9) in individuals aged ≥15 years.
Prevalence by sex was 0.8% (95%CI 0.4–1.6; 10/1213) in
males and 1.8% (95%CI 1.3–2.4; 30/1531) in females.
After adjusting for age, there was evidence (p = 0.024)
that the odds of TT were higher among females than
males, with females estimated to have 2.3 times the odds
of TT compared to males (95%CI 1.1–4.6). At the dis-
trict level, the prevalence of TT was >1% in all districts
and the lower 95%CI exceeded 0.1% in all districts.
At the commune level, three communes had a preva-
lence of 0%, seven a prevalence of between 0.1% and 1.5%,
and the remaining nine had a prevalence ≥1.5% (range
1.6–4.9%) (Table 1). The Iles Karone commune, in which
communities were over-sampled due to expected higher
trachoma prevalence, had the highest TT prevalence of all
communes (4.9%, 95%CI 1.8–12.5), whereas Sindian’s TT
prevalence was in-line with other communes at 1.3%
(95%CI 0.5–354). Two of the three communes with 0%
TT were from the communes that had been under-
sampled due to expected lower trachoma prevalence
(Tenghori Transgambienne and Thionck-Essyl), and
Bignona had a prevalence of 0.7% (95%CI 0.2–2.9). At the
community level, 28 of the 60 communities had a TT
prevalence of 0% and the remaining 32 had a prevalence
≥1% (range 1.2–14.8%) (Fig. 3).
Other trachoma grades (TI, TS, CO)
The crude prevalence of trachomatous inflammation, in-
tense (TI) in all examined individuals was 0.8%, 95%CI
0.6–1.1 (41/4979; the eyelid could not be everted for 26
individuals), and 0.5%, 95%CI 0.2–1.0 (7/1425) in chil-
dren aged 1–9 years (seven eyelids could not be everted).
The prevalence of trachomatous scarring (TS) in all indi-
viduals was 1.6%, 95%CI 1.2–2.0 (81/4979), and 2.5%,
95%CI 2.0–3.2 in those aged ≥15 years (69/2740; eyelid
could not be everted for 10 individuals, the reason for
which was not recorded). Of those aged ≥15 years with
data available, 15.4% (6/39) of those with TT had TS,
and 2.3% (63/2701) of those without TT had TS (chi-
squared p < 0.001). The overall prevalence of corneal
opacity (CO) was 0.9%, 95%CI 0.6–1.1 (43/4993), and
1.5%, 95%CI 1.1–2.0 (41/2744) in those aged ≥15 years.
Discussion
This is the first trachoma survey to be conducted in the
Bignona Department of Casamance in the Casamance
region of Senegal. The estimated prevalence of TF in 1–
9 year olds was 2.5% (95% CI 1.8–3.6) and the prevalence
Fig. 2 Point prevalence of trachomatous inflammation, follicular (TF) at community level in 1–9 year-olds. Districts: 1 = Dioloulou; 2 = Sindian;
3 = Tendouck; 4 = Tenghori. Source data: authors and open source information
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of TT in adults over the age of 14 years was 1.4% (95% CI
1.0–1.9). Both the TF and TT prevalences are lower than
those reported in Senegal’s national trachoma survey con-
ducted in 2000 (10.8% active trachoma in children
<10 years, and 2.6% TT in women aged >14 years) [15].
The prevalence of TT in women in our study was 1.8%
(95%CI 1.3–2.4).
The WHO determines that trachoma elimination has
been achieved in a country if the TF prevalence in 1–9 year
olds is <5% (precision of 4%, with a confidence interval of
2%) and the prevalence of TT cases unknown to the health
system is <0.2% (2 cases per 1000 people aged ≥15 years)
[4, 5]. In order to verify elimination, countries are required
to meet WHO criteria for elimination and to demonstrate
that this is sustainable for at least three years following
cessation of programmatic interventions.
The WHO implementation units for trachoma elimi-
nation purposes are defined as districts (population be-
tween 100,000–250,000 individuals), which are the
normal administrative unit for health care management,
sub-districts (groupings of at least three villages permit-
ting sub-unit stratification of a district) and villages
(population between 8000 and 20,000 individuals) [5].
As the Casamance district population sizes were 66,135
(Sindian), 91,322 (Tenghori), 18,033 (Tendouck) and
56,937 (Diouloulou), we interpreted prevalence data at
the Bignona Department of Casamance regional level, as
opposed to the district level, because its population size
of 232,427 equates to that of a WHO standard district
level administrative unit [4, 18]. The TF prevalence at
the regional level in 1–9 year olds was lower than the
10% WHO threshold, indicating that community MDA
is not required (although facial cleanliness and environ-
mental improvement efforts may continue), and was
lower than the 5% threshold, indicating that TF is not a
significant public health problem in this region or its
districts [4, 6]. This is supported by the low TI preva-
lence of 0.5% in 1–9 year-olds, especially as TI is less
specific as a clinical sign of trachoma than TF is [23].
Despite the encouraging TF results at the regional
level, of the 60 communities surveyed in the Bignona
Department of Casamance, two had a TF prevalence
≥10%, indicating they may require annual MDA for
three years in addition to interventions promoting facial
cleanliness and environmental improvement as proposed
by the SAFE strategy [6]. Further investigation of these
two, and their surrounding, communities is warranted to
determine whether or not this higher TF prevalence is
limited to these two communities [4]. However, as the
TF prevalence was <5% at both regional and district
levels, these communities are likely “the tail of the
decline” [4]. The 10 communities with 5–10% TF preva-
lence are recommended to receive facial cleanliness and
environmental improvement interventions, and in the
remaining 48 communities, TF control is not currently a
priority [4]. In this setting, sub-district community level
decisions regarding MDA are required to ensure that
trachoma elimination goals are achieved [4].
Fig. 3 Point prevalence of trachomatous trichiasis (TT) at community level in ≥15 year-olds. Districts: 1 = Dioloulou; 2 = Sindian; 3 = Tendouck;
4 = Tenghori. Source data: authors and open source information
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Furthermore, continued monitoring and surveillance are
required in this setting, as re-emergence of ocular C.
trachomatis infection and active trachoma has been docu-
mented in The Gambia following cessation of MDA [24].
Additionally, the Casamance region borders Guinea
Bissau to the south, where TF prevalence in 1–9 year olds
was estimated to be ≥20% in some districts. Though
Guinea Bissau has now completed three rounds of MDA
in most regions and is currently conducting impact sur-
veys, this remains a potential concern. As a result of this
risk of re-emergence, Neglected Tropical Disease (NTD)
Programmes should regularly monitor districts with previ-
ous disease to ensure that it does not re-emerge as a sig-
nificant public health problem [5]. National and regional
surveillance systems should be employed to achieve this
and should consider both active and passive surveillance
for TF and TT case-finding [5, 25].
The low TF prevalence in the Casamance region was
unexpected since no specific trachoma control efforts
have been implemented there, unlike in other regions of
Senegal or the neighbouring countries of The Gambia
and Mali [12, 13]. The natural disappearance of trach-
oma without trachoma-specific intervention has been
described elsewhere in Nepal and in one village in The
Gambia [26, 27]. These findings are thought to be asso-
ciated with the alleviation of poverty and improvements
in sanitation, water supply, education and health care
[27]. Senegal’s Human Development Index (HDI) im-
proved from 0.367 in 1990, to 0.380 in 2000, and to
0.456 in 2010. This pattern is similar to that for The
Gambia, whose HDI value increased from 0.330 in 1990,
to 0.384 in 2000, to 0.441 in 2010 [28]. Thus, it is pos-
sible that a TF prevalence decrease due to secular trend,
i.e. in the absence of trachoma control programmes,
may have occurred. This explanation is supported by the
high TT prevalence, which may represent the clinical se-
quelae from a previously higher burden of TF.
A component part of the HDI measure is educational
attainment, and low household head educational attain-
ment has been associated with TF in some countries
such as Tanzania [19], but not in The Gambia [19, 22].
The household head education levels in our study were
similar to those recorded in The Gambia [22], with
54.2% having attended school and two-thirds finishing
with primary-level education. Thus, improvements in
educational attainment are required in this region before
achieving the Millennium Development Goal of univer-
sal primary education [29].
The risk factor questionnaire enquired about ethnicity,
as the Casamance region population is distinct from
other Senegalese regions, with the predominant ethnic
group being Diola (82.4% in our study). Nationally, 44%
of the population is of Wolof ethnicity, compared with
5% of Diola ethnicity. There are no reported ethnic
group associations with trachoma in Senegal, and as the
prevalences of TF and TT were too low to conduct for-
mal risk factor analyses in our study, it was not possible
for us to explore any associations in our population. Fur-
ther investigations to assess whether ethnicity is related
to health outcomes could nonetheless be warranted, as
ethnicity has been associated with health outcomes
(such as child mortality [30]) in this region.
The environmental risk factor data provide evidence of
good water and sanitation levels in the Casamance region,
and may also help explain the low prevalence of TF we
observed. The proportion of children with unclean faces
(dirt on the face (5.4%), ocular discharge (2.4%), nasal dis-
charge (14.7%), flies on the face at the time of examination
(0.3%)) was less than that found by Faye et al. in a Trach-
oma Rapid Assessment conducted in Senegal’s Kaolack re-
gion, where 12.5% of children aged 2–5 years had dirty
faces and 4.6% had flies on their faces [16]. Latrine access
was also higher in our study at 88.4% (compared to
60.9%), and 90.4% of respondents in our study reported
that the time to fetch water was <30 min, whereas the
water source was <25 m away for only 21.3% of those in
Faye et al.’s study [16]. Environmental factors such as la-
trine and water access and use have been associated with
active trachoma [31]. Latrines likely lead to reduced fly-
eye contact, ultimately hindering transmission [32] – the
high levels of latrine access in our study may explain the
low proportion of children with flies observed on their
faces. Access to water has been associated with reduced
active trachoma, so long as it is used for hygiene purposes
[33]. However, as our questionnaire was designed to be
simple and quick in order to increase participation and
completion, whilst enabling us to assess basic environ-
mental conditions, we did not support the responses
with observations of latrine use or measurements of
water use practices, meaning we are unable to verify
the responses given.
In striking contrast to the low TF prevalence, TT
prevalence was high and far exceeded the WHO target
for elimination as a public health problem of 0.2% (2
cases per 1000 adults aged ≥15 years) at both the re-
gional and district levels [4, 5]. We found TT to be more
prevalent in females than in males (1.8% versus 0.8%),
with females having 2.3 times the odds of having TT
than males. This association, which has been reported
by others and reviewed with a meta-analysis showing a
1.8-fold higher risk of TT in females than males globally
[34], is probably because women are the predominant
caregivers and are in closer contact with children [35,
36]. However, other explanations such as females suffer-
ing higher loads of infection, being more prone to per-
sistent infection, and/or being more biologically
susceptible to consequences of C. trachomatis infection,
may also play a role [35].
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The natural history of trachoma posits that TS leads to
TT [2], and there are several non-trachomatous causes of
trichiasis, including inflammation, genetic defects and
traumas [5, 37]. Although TT was significantly associated
with having TS, with only 6/39 (15.4%) of individuals with
TT also having TS recorded, our reported TT prevalence
could be an over-estimate and could in fact be as low as
0.2% (15.4% of 1.4%). However, there is poor inter- and
intra-observer agreement of TS grading, and consequently
it is has not been included in the Global Trachoma Map-
ping Project methodology [38]. As the graders who con-
ducted this survey were trained and assessed with a focus
on TF and TT identification, we have decided to attribute
the trichiasis cases recorded to a trachomatous aetiology.
However, further work in this region to investigate
whether the trichiasis is in fact due to trachoma, or other
causes, is warranted. Notably, recent trachoma surveil-
lance recommendations are that “the presence of scar, or
the inability to evert the lid due to lid tightness, should be
taken to indicate that the trichiasis is TT” in order to
avoid misdiagnosis of TT [5].
The WHO recommends that all individuals with TT
should be offered surgery, and that surgery should be
prioritised where the prevalence is ≥0.1%. Based on the
regional population size of 232,427, our census data in-
dicating that 55.9% of the population is aged ≥15 years,
and a TT prevalence of 1.4%, there are an estimated
1819 TT surgeries to conduct. Guidelines for TT man-
agement are provided by the WHO [1, 25]. One strategy
is active TT case-hunting and surgery camps, as done in
The Gambia, with surgeries recorded in a central, elec-
tronic TT registry to enable consistent data collection
from across the region and ensuring appropriate follow-
up care of all cases identified [12].
Limitations of the study are that there was not suffi-
cient statistical power to conduct a risk factor analysis
for TF due to the low prevalence, and that the sample
size target of 2732 children aged 1–9 years was not
achieved, with only 1432 children examined. Strengths
of the study include providing the first data on TF and
TT prevalence in this region, obtaining environmental
data within which to contextualise the prevalence data,
and capacity building within the region by having suc-
cessfully trained 40 individuals from the region through
a mixture of workshops and field exercises.
Conclusions
The prevalence of TF in 1–9 year olds in the region and
its districts was below the WHO 5% threshold for elim-
ination, indicating that trachoma control for TF is not a
priority in this setting. However, adequate monitoring
and surveillance of TF at sub-district level will be re-
quired to ensure that elimination targets are sustained
and that TF does not re-emerge as a public health
problem. TT surgery remains the priority for trachoma
elimination efforts in the region. The prevalence of TT
far exceeds the 0.2% WHO threshold in adults aged
≥15 years for elimination of trachoma as a public health
problem, with surgery needing to be prioritised urgently
to meet the WHO elimination targets.
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